Ingen Technologies IncOver The Counter Market:IGNT
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ingen Technologies Inc | 1.7K | 0.0x | --- |
Home Solutions Health Inc | 250.0 | 0.0x | --- |
Global Wholehealth Partners Corp | 130.0 | 0.0x | --- |
SurgLine International Inc | 5.7K | 0.0x | --- |
Lexington Biosciences Holdings Corp | 40.0 | 0.0x | --- |
CardioGenics Holdings Inc | 100.0 | 0.0x | --- |
Company Information
Ingen Technologies, Inc. is engaged in research and development of home healthcare products for the respiratory market. The Company develops products for the treatment of chronic obstructive pulmonary disease (COPD), such as chronic bronchitis, emphysema and asthmatic bronchitis, all of which obstruct airflow from the lungs. It is a cause of death, illness and disability in the United States, and other countries. The Company’s products include The Smart Nasal Cannula 206NCA (Adult Size), The Smart Nasal Cannula 203NCA (Adult Size), The Smart Nasal Cannula 206NCP (Child Size), The Smart Nasal Cannula 203NCP (Child Size), The Smart Nasal Cannula 206NC (Infant Size), The Smart Nasal Cannula 203NC (Infant Size), Oxyview 203A And Oxyview 206A.
Contact Information
- Headquarters
- 3410 La Sierra Ave Ste F507RIVERSIDE, CA, United States 92503
- Phone
- 951-688-7840
- Fax
- 951-688-8802
Executives
- Chairman of the Board, Chief Operations Officer, Secretary
- Gary Tilden
- Chief Executive Officer, Director
- David Hanson
- Chief Financial Officer, Director
- Thomas Neavitt
- Director
- Richard Campbell
- Director
- Michael Cooper
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.7K |
|---|---|
Revenue (TTM) | $4.6K |
Shares Outstanding | 1.7B |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.81 |
EPS | $-0.04 |
Book Value | $-0.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.4 |
Price/Cash Flow (TTM) | 0.0x |
Operating Margin | 500.22% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
